Second-generation antihistamines in asthma therapy: is there a protective effect? (Q34544512)

2 August 2017

1 reference

title

Second-generation antihistamines in asthma therapy: is there a protective effect? (English)

1 reference

2 August 2017

0 references

1 reference

Garry M Walsh

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

27-34

1 reference

Fortnightly review: modern drug treatment of chronic asthma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Upper airway inflammatory diseases and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

21 January 2018

Antihistamines in asthma

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Spontaneous histamine release and histamine content in normal subjects and subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

New insights into the second generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

H(1)-antihistamines and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Advances in the immunobiology of eosinophils and their role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

T1 and T2 CD4+ cells in human allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Prophylactic treatment of grass pollen-induced asthma with cetirizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Treatment of bronchial asthma with terfenadine; a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Cardiotoxic effect with convulsions in terfenadine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Molecular pharmacological aspects of histamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Protective effect of different doses of terfenadine on the conjunctival provocation test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

Pharmacokinetic Optimisation of Histamine H1-Receptor Antagonist Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257160

21 January 2018

Identifiers

DOI

10.1007/BF03257160

1 reference

2 August 2017

1 reference